Synopsis of recent research by authors named "Ai-Xue Li"
- Ai-Xue Li's research primarily focuses on immunotherapy, particularly through the development of innovative drug delivery systems that enhance the targeting and efficacy of treatments for tumors.
- A key finding from Li's recent work highlights the use of immunocyte membrane-coated nanocarriers, which demonstrate high specificity and biocompatibility, addressing the challenges presented by the tumor immune microenvironment and individual patient variability.
- Additionally, Li's earlier research involves the identification of MHC class I genes in Platyrrhini species, contributing to a better understanding of the adaptive immune system's gene diversity and its implications for immunological studies in primates.
